Beyond Face Value - Part 1
Overview
When it comes to minimally-invasive facial rejuvenation, what's possible with today's tools? What's expected? What's appropriate? Sachin M. Shridharani, MD and Jason D. Bloom, MD outline principles of facial aesthetics, discuss important anatomical considerations, review data about patient expectations, and outline effective approaches to full-face rejuvenation.Supported by a educational grant from Allergan. Learning Objectives
Upon completion of this activity, the participant should be able to: - Describe the properties of different injectable fillers and explain how these properties provide different lifting/filling effects.
- Devise strategies for facial rejuvenation that employ the unique characteristics of different fillers to achieve complementary effects.
- Identify opportunities for combination strategies for rejuvenation that optimize aesthetic outcomes, patient convenience, cost, and satisfaction.
- Describe the potential effects of facial rejuvenation on the patient psyche and discuss possible impact on quality of life.
- Utilize strategies to elicit patient desires and deliver combination approaches to facial rejuvenation that meet patient objectives.
Accreditation
Accreditation Statement Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA Credit Designation Statement Evolve Medical Education LLC designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
The following faculty members have the following financial relationships with commercial interests: Jason D. Bloom, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan plc; Alma Lasers; Galderma Laboratories L.P.; InMode; Merz Pharma; Pharmaceutical Project Solutions (PPSI); Sinclair Pharma; and ThermiGen, LLC. Grant/Research Support: Allergan plc, Galderma Laboratories L.P.; and ZELTIQ Aesthetics, Inc. Stock/Shareholder: Cearna Inc. Sachin Shridharani, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan plc; Galderma Laboratories L.P.; Merz Pharma; and Mira Mar, Inc. Grant/Research Support: Allergan plc. Editorial Support Disclosure Cheryl Cavanaugh, MS, Evolve Medical Education LLC and Anthony Rossi, Peer Reviewer have no real or apparent conflicts of interest to report.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
